Aranesp (darbepoetin alfa) Injection, 100 mcg/mL, Single-Dose Vial, 1 mL, 4/Package

Aranesp (darbepoetin alfa) is a recombinant erythropoiesis-stimulating agent indicated for the treatment of anemia associated with chronic kidney disease and for anemia in patients with non-myeloid malignancies receiving chemotherapy. This formulation is supplied as a 100 mcg/mL solution in a 1 mL single-dose vial, packaged 4 vials per package. It is intended for intravenous or subcutaneous administration under medical supervision.